Stromal biology and therapy in pancreatic cancer: a changing paradigm.
about
Targeting inflammation in pancreatic cancer: Clinical translationGenetics and biology of pancreatic ductal adenocarcinomaExtra-pancreatic invasion induces lipolytic and fibrotic changes in the adipose microenvironment, with released fatty acids enhancing the invasiveness of pancreatic cancer cells.The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients.DNA methylation in the tumor microenvironment.Chemotherapy and tumor microenvironment of pancreatic cancer.Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal AdenocarcinomaThe prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinomaDiffusion-weighted and dynamic contrast-enhanced MRI of pancreatic adenocarcinoma xenografts: associations with tumor differentiation and collagen content.ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.Mesopancreatic Stromal Clearance Defines Curative Resection of Pancreatic Head Cancer and Can Be Predicted Preoperatively by Radiologic Parameters: A Retrospective StudyStromal ETS2 Regulates Chemokine Production and Immune Cell Recruitment during Acinar-to-Ductal Metaplasia.Quantitative secretomic analysis of pancreatic cancer cells in serum-containing conditioned medium.Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in human pancreatic cancer.The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome.ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth.Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers.Prognostic role and correlation of CA9, CD31, CD68 and CD20 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma.Prognostic value and clinicopathological features of PD-1/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancreatic cancer.Advanced pancreatic ductal adenocarcinoma - Complexities of treatment and emerging therapeutic options.ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer.Evolving treatment landscape for early and advanced pancreatic cancer.Seed-in-Soil: Pancreatic Cancer Influenced by Tumor Microenvironment.Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenografts.Pancreatic cancer stroma: controversies and current insights.Pancreatic ductal adenocarcinoma: is a cure possible?S-1 plus nab-paclitaxel is a promising regimen for pancreatic cancer in a preclinical model.Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinomaPanIN Neuroendocrine Cells Promote Tumorigenesis via Neuronal Cross-talk.Pancreatic cancer biology and genetics from an evolutionary perspective.New insights in the development of pancreatic cancer.Epigenetic control of the tumor microenvironment.Can diffusion-weighted imaging serve as a biomarker of fibrosis in pancreatic adenocarcinoma?Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts.Human pancreatic stellate cells modulate 3D collagen alignment to promote the migration of pancreatic ductal adenocarcinoma cells.Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer.The pancreatic cancer microenvironment: A true double agent.The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.
P2860
Q26751686-B359DF55-9DC4-4984-8826-0DB3A8D58A85Q26765438-9D982AA5-285F-4801-8E61-6823F2F25F4EQ33566915-9F53EC67-17A2-4BEA-BA6F-763FEB808555Q33624392-157D574A-275D-4808-9FB9-301DFD056F76Q33722994-5C4B6D67-0C35-44A7-8664-095BC0A66E36Q33876637-ADA38F74-BD13-408B-8FF0-5B78AF049FABQ36134440-F1A17C36-D9D7-43DE-889A-27A094312886Q36782384-3C71851B-8F90-4A44-B222-935696165FD8Q36980838-925546DF-BFAD-40A9-B982-5E8B6B34CD60Q37030917-B155D2A9-996C-494D-9CF5-98B0675A03D6Q37204959-65C4234E-3C11-4962-AE29-E1A9B74A6673Q37273793-3802ED72-4F68-439E-B23A-0C1D1DBBCD4DQ37424687-1DA6C405-088A-46B0-AAE1-BA083C90D149Q37455222-9F14497B-D7C4-4047-B489-BAD3401895DAQ37557707-45217F8A-F26C-43C9-AE41-B46D68CB75CAQ37618014-53532195-5786-4F31-A418-CBD79804F70CQ37658419-26C67C27-7122-4C48-B006-F8BCB57AE311Q37687298-98EC26A2-15F9-4349-849A-6E243307399EQ37688099-767DF98B-DE1C-44FE-B4BB-EDE0021138E3Q37697130-65993C2F-0C8E-4BED-95D0-3ACD60BC94F3Q37705966-0ECC3B28-BBB4-4CA8-BBEC-4023169EFB5DQ37742975-87563DF5-C5AD-4291-AC68-3670612D2A63Q38601572-5F05BBE0-E99E-441B-8853-A1F46305DA01Q38624806-3CD6C8F5-3C89-480E-879D-6486FE248DCCQ38650250-C9DB64B3-D748-4034-A69C-BA37FB231C31Q38665197-94801AA4-EFC8-47AA-A2CE-FCC4C070ABEAQ38748372-44716B5D-C1FC-4BF6-A58C-D1F6F535D836Q38749836-261ED8FD-261F-408A-B29A-210F753BC9EDQ38776511-FF6419C6-26D2-40E5-8F05-B0C61C384A9AQ38779589-4906629A-5DA1-48CE-81B8-ED4D478B394DQ38849004-FF2A9620-51E1-4A55-9553-4CE752F13199Q38904824-C52496EE-0455-4E9E-9E2B-E74B45B5C987Q38907393-F4ED88CF-D3FD-4FA2-B180-9C9A5E4F3C79Q38971785-EAC13505-77C0-4860-8DFB-61904E1966A6Q39115648-D29D3287-40D6-4FFE-9D4F-B5BBA2326EA7Q39204274-618546B3-D6A6-49FE-B1A0-C1B2508C8E9BQ39210150-369ADDD2-5117-4AE1-90B0-2051217668BFQ39235761-AED7B513-4C44-4D9F-91FD-E74C835935FAQ39366753-5C931734-A53E-4A61-9E2D-3A616A026E7FQ40969084-C19B24DE-468B-48E5-B316-044C003C6390
P2860
Stromal biology and therapy in pancreatic cancer: a changing paradigm.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Stromal biology and therapy in pancreatic cancer: a changing paradigm.
@en
type
label
Stromal biology and therapy in pancreatic cancer: a changing paradigm.
@en
prefLabel
Stromal biology and therapy in pancreatic cancer: a changing paradigm.
@en
P2860
P50
P1433
P1476
Stromal biology and therapy in pancreatic cancer: a changing paradigm.
@en
P2093
Albrecht Neesse
P2860
P304
P356
10.1136/GUTJNL-2015-309304
P407
P577
2015-05-20T00:00:00Z